328 related articles for article (PubMed ID: 31453785)
1. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China.
Zheng T; Liu H; Qin L; Chen B; Zhang X; Hu X; Xiao L; Qin S
Metabolism; 2018 Oct; 87():105-112. PubMed ID: 29572131
[TBL] [Abstract][Full Text] [Related]
4. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
[TBL] [Abstract][Full Text] [Related]
5. Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction.
Chakraborty A; Hegde S; Praharaj SK; Prabhu K; Patole C; Shetty AK; Mayya SS; Acharya RV; Hande HM; Prabhu MM; Upadhya D
Front Endocrinol (Lausanne); 2021; 12():798652. PubMed ID: 35035379
[TBL] [Abstract][Full Text] [Related]
6. Reduced Serum Levels of Brain-Derived Neurotrophic Factor Are Related to Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.
Sun ZC; Yu J; Liu YL; Hong ZZ; Ling L; Li GQ; Zhuo YF; Wang WR; Zhang Y
Ann Nutr Metab; 2018; 73(4):271-281. PubMed ID: 30308512
[TBL] [Abstract][Full Text] [Related]
7. Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.
Wang J; Yuan Y; Cai R; Huang R; Tian S; Lin H; Guo D; Wang S
J Alzheimers Dis; 2018; 63(2):835-845. PubMed ID: 29689724
[TBL] [Abstract][Full Text] [Related]
8. Association of Plasma DPP4 Activity With Mild Cognitive Impairment in Elderly Patients With Type 2 Diabetes: Results From the GDMD Study in China.
Zheng T; Qin L; Chen B; Hu X; Zhang X; Liu Y; Liu H; Qin S; Li G; Li Q
Diabetes Care; 2016 Sep; 39(9):1594-601. PubMed ID: 27371673
[TBL] [Abstract][Full Text] [Related]
9. Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients.
Jiang Y; Wang S; Liu X
BMC Endocr Disord; 2022 May; 22(1):137. PubMed ID: 35610700
[TBL] [Abstract][Full Text] [Related]
10. GSK-3β activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study.
Gao Y; Yu H; Liu Y; Xu Z; He B; Liu H; Wang Y; Zhang Y; Liang Y; Yang Y; Zheng J; Wang JZ
J Diabetes; 2024 Jan; 16(1):e13470. PubMed ID: 37700547
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma Interleukin-1β level is associated with memory deficits in type 2 diabetic patients with mild cognitive impairment.
Tian S; Huang R; Han J; Cai R; Guo D; Lin H; Wang J; Wang S
Psychoneuroendocrinology; 2018 Oct; 96():148-154. PubMed ID: 29957442
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.
Liu J; Yang W; Luo H; Ma Y; Zhao H; Dan X
Aging Clin Exp Res; 2021 Jun; 33(6):1659-1666. PubMed ID: 32892314
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study.
Ng TKS; Coughlan C; Heyn PC; Tagawa A; Carollo JJ; Kua EH; Mahendran R
Aging (Albany NY); 2021 Oct; 13(19):22666-22689. PubMed ID: 34607976
[TBL] [Abstract][Full Text] [Related]
14. Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.
Huang X; Wang J; Zhang S; Zhao X; An R; Lan Y; Yi M; Wan Q
J Alzheimers Dis; 2024; 99(4):1261-1271. PubMed ID: 38788070
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section study.
Chen RH; Jiang XZ; Zhao XH; Qin YL; Gu Z; Gu PL; Zhou B; Zhu ZH; Xu LY; Zou YF
Ann Endocrinol (Paris); 2012 Jun; 73(3):208-12. PubMed ID: 22704263
[TBL] [Abstract][Full Text] [Related]
16. Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients.
Wu P; Zhao Y; Zhuang X; Sun A; Zhang Y; Ni Y
Clin Neurol Neurosurg; 2018 Nov; 174():203-206. PubMed ID: 30273843
[TBL] [Abstract][Full Text] [Related]
17. Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment.
Tian S; Han J; Huang R; Sun J; Cai R; Shen Y; Wang S
J Alzheimers Dis; 2017; 58(4):1163-1173. PubMed ID: 28550262
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Plasma DPP4 Activity to BDNF Ratio and Mild Cognitive Impairment in Elderly Population With Normal Glucose Tolerance.
Xiao L; Ge B; Chen X; Chen B; Qin L; Hu X; Pan H; Chen Y; Tian L; Gao Y; Zheng T
Front Aging Neurosci; 2019; 11():33. PubMed ID: 30886577
[No Abstract] [Full Text] [Related]
19. Elevated Plasma Free Fatty Acid Susceptible to Early Cognitive Impairment in Type 2 Diabetes Mellitus.
Zhu W; Xu L; Zhang H; Tian S; An K; Cao W; Shi J; Tang W; Wang S
J Alzheimers Dis; 2021; 82(3):1345-1356. PubMed ID: 34151809
[TBL] [Abstract][Full Text] [Related]
20. Analysis of correlation between the mild cognitive impairment (MCI) and level of adiponectin in elderly patients with type 2 diabetes mellitus (T2DM).
Liu ZQ; Zhang MX; Wang J; Ding N
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5471-5477. PubMed ID: 29243792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]